Surrozen (SRZN) Share-based Compensation (2020 - 2026)

Surrozen (SRZN) recorded quarterly Share-based Compensation of $2.1 million in Q1 2026, up 110.08% quarter-over-quarter from $1.0 million in Q4 2025, and up 152.4% on a YoY basis from $834000.0 in Q1 2025.

Surrozen (SRZN) Share-based Compensation (2020 - 2026) Analysis & Trends

Surrozen's Share-based Compensation history runs 7 years deep, the most recent figure standing at $2.1 million for Q1 2026.

  • In Q1 2026, Share-based Compensation rose 152.4% year-over-year to $2.1 million; the TTM figure through Mar 2026 stood at $5.1 million (up 30.32% YoY), while the FY2025 annual figure was $3.8 million, down 6.78% from the prior year.
  • Share-based Compensation was $2.1 million for Q1 2026 at Surrozen, up from $1.0 million in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $2.1 million in Q1 2026 to a low of $834000.0 in Q1 2025.
  • Historically, Share-based Compensation has averaged $1.1 million across 5 years, with a median of $1.0 million in 2024.
  • The sharpest annual moves came in 2023 and 2026: Share-based Compensation retreated 24.14% in 2023, then jumped 152.4% in 2026.
  • A 5-year view of Share-based Compensation shows it stood at $1.5 million in 2022, then declined by 24.14% to $1.2 million in 2023, then slipped by 23.21% to $900000.0 in 2024, then climbed by 11.33% to $1.0 million in 2025, then soared by 110.08% to $2.1 million in 2026.
  • The last three Share-based Compensation figures came in at $2.1 million (Q1 2026), $1.0 million (Q4 2025), and $1.0 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn - -
2 Belite Bio 55,800.00 Bn 55,800.00 Bn - -
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn - -
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn -
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn - 305,000.00
6 Evaxion A 1,567.96 Bn 1,567.94 Bn - -
7 Psyence Biomedical 251.43 Bn 251.42 Bn - -
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn 166.40 Mn
9 Abivax 94.37 Bn 94.37 Bn - 26.47 Mn
10 Surrozen 225,877.86 -106.68 Mn - 2.11 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 2.11 Mn
Mar 31, 2026 2.11 Mn
Dec 31, 2025 1.00 Mn
Dec 31, 2025 1.00 Mn
Sep 30, 2025 1.01 Mn
Sep 30, 2025 1.01 Mn
Jun 30, 2025 994,000.00
Jun 30, 2025 994,000.00
Mar 31, 2025 834,000.00
Mar 31, 2025 834,000.00
Dec 31, 2024 900,000.00
Dec 31, 2024 900,000.00
Sep 30, 2024 1.04 Mn
Sep 30, 2024 1.04 Mn
Jun 30, 2024 1.15 Mn
Jun 30, 2024 1.15 Mn
Mar 31, 2024 1.03 Mn
Mar 31, 2024 1.03 Mn
Dec 31, 2023 1.17 Mn
Dec 31, 2023 1.17 Mn